Cerebral amyloid angiopathy (CAA) is the deposition of amyloid proteins in the cerebrovasculature, which can lead to intracerebral hemorrhage. Intracerebral hemorrhage in CAA often presents with microhemorrhages and, less frequently, with more devastating macrohemorrhages. We present a case of CAA-related synchronous bilateral intracerebral macrohemorrhage which, to our knowledge, has yet to be reported in the literature, and postulate its relationship to antiplatelet therapy and transient elevations in blood pressure.
Introduction
Cerebral amyloid angiopathy (CAA) is the deposition of amyloid proteins in the cerebrovasculature. CAA is a well-known and relatively common etiology for intracerebral hemorrhage (ICH), with a predilection for the meningocortical vasculature [1, 2] . In the elderly, CAA is the second most common cause of nontraumatic ICH after hypertension [3, 4] . While CAA is a relatively frequent cause of ICH, large synchronous bilateral lobar hemorrhage secondary to CAA is a rare but devastating event, which may be related to transient elevations in blood pressure and aspirin use.
A previously healthy 68-year-old woman awoke in the morning with dizziness which, by early evening, progressed to nausea, vomiting and a severe headache. Within 60 min of headache onset she became confused and somnolent. She had no history of hypertension, coagulopathy or illicit drug use. There was a history of low-dose aspirin use, which had reportedly been taken the day prior to the event. Upon initial presentation the patient's blood pressure was 178/70 mm Hg and pulse 72 bpm. A CT scan displayed intraparenchymal hemorrhages involving the left parietal and bilateral temporal lobes and a 3-mm rightward midline shift. Approximately 3 h after headache onset, the patient's blood pressure was 189/68 mm Hg, pulse 59 bpm and respiratory rate 9/min. MRI showed large areas of parenchymal hemorrhage in the right and left temporal lobes, the left parietal region and the right tentorium ( fig. 1 ). Small foci of restricted diffusion near the vertex and the posterior limb of the internal capsule were present. There was no abnormal enhancement following contrast administration. No source of hemorrhage was identified on cerebral angiography. Transthoracic echocardiography did not reveal valvular pathology. Blood cultures were negative. A brain biopsy was planned but not performed due to brain herniation and a worsening neurologic examination. The patient died on hospital day four.
A complete autopsy was performed. Gross neuropathologic examination revealed intraparenchymal hemorrhage involving the left and right temporal lobes, softening of the medial temporal lobes secondary to transtentorial herniation and punctate hemorrhages in the superior portion of the left temporal lobe. Microscopic examination of the brain showed hemorrhagic infarctions within the bilateral temporal lobes, the right frontal and parietal lobes and the left occipital lobe. Thickened, hyalinized blood vessels were noted in the frontal, temporal, parietal and occipital lobes. Congo red stain and beta-amyloid immunohistochemical stains displayed multiple congophilic and beta-amyloid-reactive blood vessels ( fig. 2 ) as well as neuritic plaques. Blood vessels adjacent to regions of hemorrhage showed microangiopathic change, with fibrinoid necrosis in addition to hyalinosis of the vessel walls. While no definite parenchymal microhemorrhages were identified by imaging, occasional foci of perivascular hemosiderin deposition with spongiosis indicative of prior hemorrhage were found on microscopic examination. Vascular malformations, onion-skin-type thickening or lipohyalinosis characteristic of hypertensive microangiopathy and saccular aneurysms were not identified. There were not significant numbers of perivascular inflammatory cells, providing no support for vasculitis. Grocott methenamine silver stain and Gram stain were negative for microorganisms. PCR of brain tissue did not detect the presence of HSV-1 or HSV-2 nucleic acid. Culture of brain tissue and immunohistochemical staining for HSV-1 and HSV-2 were negative.
Discussion
The differential diagnosis for multiple ICH includes CAA, hypertensive encephalopathy, CNS vasculitis, arteriovenous malformations and coagulopathy. Hypertension is the most common cause of nontraumatic brain hemorrhage, followed by CAA. The clinical history and laboratory evaluation aid in excluding other diagnostic entities with reasonable certainty. Whereas hypertensive ICH tends to affect deep nuclei of the brain, CAA is a meningocortical angiopathy and therefore shows a predilection for lobar hemorrhage [2] . CAA is most often sporadic, with rare familial forms. Sporadic CAA is associated with Alzheimer's pathology, which this patient showed in the form of beta-amyloid-reactive plaques. Both conditions are characterized by accumulation of Aβ, a beta-amyloid precursor protein cleavage product. Accumulation of a shorter variant of the cleavage product is found in CAA (39-40 residues) and a longer variant in Alzheimer's disease (42-43 residues) [5, 6] . The Boston criteria were developed to determine the probability of CAA-related hemorrhage based on imaging findings and clinical data, as tissue is often not available for histologic examination [7] . In patients ≥55 years of age with lobar, cortical or cortico-subcortical hemorrhage and lacking known risk factors or causes for hemorrhage, such as warfarin treatment, head injury or neoplasm, CAA is considered 'probable' in those with multiple hemorrhages and 'possible' in those with a single hemorrhage. Imaging findings in CAArelated hemorrhage may demonstrate asymptomatic microhemorrhages (≤5 mm) or clinically significant macrohemorrhages (>5 mm) involving the cerebral and/or cerebellar cortices but not the deep gray matter [8] . While our patient did not demonstrate unequivocal microhemorrhages, the presence of bilateral lobar hemorrhages, age ≥55 years and the absence of other identifiable precipitating causes would initially classify this case as 'probable CAA-related hemorrhage', with necropsy serving to confirm the diagnosis.
Lowering of blood pressure likely reduces the risk of CAA-related hemorrhage [9] , which corroborates the notion that elevations in blood pressure may act as a precipitant. Furthermore, the current American Heart Association/American Stroke Association guidelines for ICH recommend a target blood pressure of 160/90 mm Hg and a mean arterial pressure of 110 mm Hg [10] as significant elevations in blood pressure can promote hematoma expansion. Our patient initially presented with a systolic blood pressure of 178 mm Hg. It is unclear whether the patient's blood pressure was elevated prior to the hemorrhagic event or whether the hypertension was a component of an evolving Cushing-Kocher response. In either scenario, hypertension seems to have been a plausible initiating and/or exacerbating factor in the development of the patient's large bilateral hemorrhages. It is also known that the patient had been using aspirin 81 mg prior to presentation. The prevalence of cerebral microbleeds and the risk of recurrent ICH are increased in aspirin users with CAA [11, 12] , suggesting that aspirin use is a risk factor for ICH in CAA and may have also contributed to the severity of the patient's condition.
Multiple ICHs serve as a diagnostic hallmark for the diagnosis of CAA. Interestingly, synchronous bilateral macrohemorrhages are a seemingly rare event and, to our knowledge, have yet to be reported in the literature. We posit that transient elevations in blood pressure in conjunction with aspirin use may be inciting factors for this type of presentation.
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